34
Reputation
Low
2 open positions
Last updated Apr 24, 2026
Founded 2023
5 employees
Scientist, Cancer Modeling
16
About Us Cloverleaf Bio is an early-stage therapeutics company that is developing a new class of engineered tRNA therapeutics. Our tRNAs target an underappreciated vulnerability of cancer: addiction to high levels of tRNA modifying enzymes. Cloverleaf’s approach to drugging tRNA modifying enzymes us
OtherScientist Cancer ModelingMid
See 2 similar>
Quick Apply
0 0 0
0 views0 saves 0 applied
Scientist, RNA Biochemistry
16
About Us Cloverleaf Bio is an early-stage therapeutics company that is developing a new class of engineered tRNA therapeutics. Our tRNAs target an underappreciated vulnerability of cancer: addiction to high levels of tRNA modifying enzymes. Cloverleaf’s approach to drugging tRNA modifying enzymes us
OtherScientist Rna BiochemistryMid
See 2 similar>
Quick Apply
0 0 0
0 views0 saves 0 applied
Insights will appear once this company has published more listings.